Global Stereotactic Surgery Devices Market to Reach $28.89 Billion by 2029, Growing at 6% CAGR

What market dynamics are playing a key role in accelerating the growth of the stereotactic surgery devices market?
The surge in Parkinson's disease and epilepsy cases is projected to stimulate the progress of the stereotactic surgical device market. Parkinson's disease is a neurodegenerative disorder resulting in uncontrollable shaking, slow movement, and rigid muscles, while epilepsy is a neurological condition that targets the brain and makes patients vulnerable to repetitive, uncontrollable seizures. Stereotactic surgical devices find their use in treating movement disorders, epilepsy, pain, and psychiatry, including Parkinson's disease. For example, according to the 2022 study by the Parkinson's Foundation, a national nonprofit organization based in New York, over 90,000 people will be diagnosed with Parkinson's disease annually in the United States. This is an increase of 50% from the previously projected annual rate of 60,000 diagnoses. Parkinson's disease affects close to a million people in the United States, and the figure is expected to rise to 1.2 million by 2030. Consequently, the mounting instances of Parkinson's disease and epilepsy catalyze the expansion of the stereotactic surgical device market.

Get Your Stereotactic Surgery Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report

How will the growth rate of the stereotactic surgery devices market shape industry trends by 2034?
The market size of stereotactic surgery devices has demonstrated a consistent increase over the last few years. The market is anticipated to expand from $21.8 billion in 2024 to $22.63 billion in 2025, evidencing a compound annual growth rate (CAGR) of 3.8%. Factors such as the transition to minimally invasive practices, the incorporation of robotics and automation, a heightened need for precision and accuracy, as well as enhanced safety profiles have significantly contributed to the growth experienced during the historical period.

The market for stereotactic surgery devices is poised to witness significant expansion in the forthcoming years. With a projected compound annual growth rate (CAGR) of 6.3%, the market will flourish to "$28.89 billion by the year 2029. This surge is primarily due to factors such as an increasing number of cancer cases, integration of artificial intelligence and machine learning, growth in novel medical specialties, an upsurge in the elderly population, and a drive towards individualized treatments. Key trends anticipated in the forecast period encompass advancements in precision and accuracy, downsizing of devices, the infusion of robotics and automation, tailor-made treatment methodologies, and wider application scopes and procedures.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

What trends are poised to drive the future success of the stereotactic surgery devices market?
The rising trend of technological advancements is increasingly becoming influential in the stereotactic surgical device market. Key market players are focusing on creating innovative technologies to assert their dominance in the market. A notable example is Brainlab, a medical technology firm based out of Germany. They released a new product named ExacTrac Dynamic Surface in May 2023. The product is a surface guided radiation therapy (SGRT) system that tracks and positions patients. It integrates high-speed thermal surface tracking technology with an upgraded version of ExacTrac X-ray monitoring. This enhances the versatility and accuracy in patient positioning and tracking across different treatments like cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system projects a structured blue light pattern onto the patient's body surface. This light pattern is captured by two 3D cameras. Additionally, every surface point gets augmented with a thermal signature captured by the third, in-unit camera.

Which primary segments of the stereotactic surgery devices market are driving growth and industry transformations?
The stereotactic surgery devices market covered in this report is segmented -

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories

Subsegments:
1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon
2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC
3) By Proton Beam: Fixed Beam Proton Therapy Systems, Scanned Beam Proton Therapy Systems
4) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10495

Which geographical regions are pioneering growth in the stereotactic surgery devices market?
North America was the largest region in the stereotactic surgery devices market in 2024. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the stereotactic surgery devices market landscape?
Major companies operating in the stereotactic surgery devices market include Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

What Is Covered In The Stereotactic Surgery Devices Global Market Report?

• Market Size Forecast: Examine the stereotactic surgery devices market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the stereotactic surgery devices market for a structured understanding.
• Key Players Overview: Analyze major players in the stereotactic surgery devices market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the stereotactic surgery devices market.
• Segment Contributions: Evaluate how different segments drive overall growth in the stereotactic surgery devices market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the stereotactic surgery devices market.
• Industry Challenges: Identify potential risks and obstacles affecting the stereotactic surgery devices market.
• Competitive Landscape: Review strategic developments in the stereotactic surgery devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.